{"id":105338,"date":"2022-06-23T16:02:36","date_gmt":"2022-06-23T20:02:36","guid":{"rendered":"http:\/\/www.bumc.bu.edu\/busm\/?p=105338"},"modified":"2022-06-23T16:05:26","modified_gmt":"2022-06-23T20:05:26","slug":"researchers-untangle-the-apoe4-gene-the-most-significant-genetic-risk-factor-for-alzheimers-disease","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/camed\/2022\/06\/23\/researchers-untangle-the-apoe4-gene-the-most-significant-genetic-risk-factor-for-alzheimers-disease\/","title":{"rendered":"Researchers Untangle the APOE4 Gene, the Most Significant Genetic Risk Factor for Alzheimer\u2019s Disease"},"content":{"rendered":"<p>&nbsp;<\/p>\n<figure id=\"attachment_105343\" aria-describedby=\"caption-attachment-105343\" style=\"width: 210px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" src=\"\/camed\/files\/2022\/06\/Alzheimers-brain-cell-e1656014517308.jpg\" alt=\"Alzheimer's brain cell - translucent white against green background\" class=\"size-full wp-image-105343\" width=\"200\" height=\"266\" \/><figcaption id=\"caption-attachment-105343\" class=\"wp-caption-text\">Alzheimer&#8217;s brain cell<\/figcaption><\/figure>\n<p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists have discovered some genetic variants that increase the risk for developing Alzheimer\u2019s; the most well-known of these for people over the age of 65 is the <em>APOE <\/em>\u03b54 allele. Although the association between <em>APOE4 <\/em>and increased AD risk is well-established, the mechanisms responsible for the underlying risk in human brain cell types has been unclear until now.<\/p>\n<p>BUSM researchers have discovered two important novel aspects of the gene: 1) human genetic background inherited with <em>APOE4<\/em> is unique to <em>APOE4<\/em> patients and 2) the mechanistic defects due to <em>APOE4<\/em> are unique to human cells.<\/p>\n<p><img loading=\"lazy\" src=\"\/camed\/files\/2022\/03\/Julia-TCW-e1656014298395.jpg\" alt=\"Headshot of Julia TCW\" class=\"alignright size-full wp-image-102458\" width=\"150\" height=\"150\" \/>\u201cOur study demonstrated what the <em>APOE4<\/em> gene does and which brain cells get affected the most in humans by comparing human and mouse models. These are important findings as we can find therapeutics if we understand how and where this risk gene is destroying our brain,\u201d says corresponding author Julia TCW, PhD, assistant professor of pharmacology &amp; experimental therapeutics.<\/p>\n<p>To investigate the effects of <em>APOE4<\/em> on brain cell types, the researchers used three models, human induced pluripotent stem cells (hiPSCs), post-mortem human brains and experimental models. They used a population hiPSC model, comparing <em>APOE4<\/em> (mutation) vs. <em>APOE3 <\/em>(mutation-free) of AD patients and normal people. For the second model, they compared AD brains against a control brain with different <em>APOE<\/em> genotypes. For the third model, they used an experimental model carrying human <em>APOE<\/em> genes. With all, they used genetic screening and RNA sequencing to identify human cell-type specific defects due to <em>APOE4<\/em>.<\/p>\n<p>\u201cOur study supports that the genetic background around <em>APOE<\/em> region can modify the <em>APOE4 <\/em>risk effects. Therefore, apart from finding drugs to reduce the <em>APOE4<\/em> risk, modulating targets to mimic brains carrying protective genes or genetic backgrounds can be another strategy to reduce the risk of developing AD,\u201d adds TCW.<\/p>\n<p>While this study is about <em>APOE4<\/em> gene using Alzheimer\u2019s patient samples, it is also known that <em>APOE4 <\/em>is risk for Parkinson\u2019s disease (PD). According to TCW, this study has implications for any disease associated with <em>APOE<\/em> as risk such as AD and PD, or for any disease phenotype found similar to the one caused by <em>APOE4<\/em>, such as rare genetic diseases.<\/p>\n<p>These findings appear <a href=\"https:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(22)00648-1\">online<\/a> in the journal <em>Cell<\/em>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Findings may lead to new strategies, drugs to combat the condition.<\/p>\n","protected":false},"author":903,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[90],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/105338"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/users\/903"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/comments?post=105338"}],"version-history":[{"count":7,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/105338\/revisions"}],"predecessor-version":[{"id":105347,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/105338\/revisions\/105347"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/media?parent=105338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/categories?post=105338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/tags?post=105338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}